CD13 induces stem cell characteristics and MDR of hepatoma cells, and CD13+ cells in liver cancer transplants show higher proliferation and greater resistance to doxorubicin and 5-fluorouracil than CD13− cells [42, 43]. This evidence concerns the gene ANPEP and hepatocellular carcinoma.